ClinicalTrials.Veeva

Menu
A

Asthma Bhawan | Clinical Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Nintedanib
BMS-986278
Revamilast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

Enrolling
Idiopathic Pulmonary Fibrosis
Drug: BMS-986278
Drug: BMS-986278 Placebo

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Enrolling
Progressive Pulmonary Fibrosis
Drug: BMS-986278 Placebo
Drug: BMS-986278

Trial sponsors

Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems